Plain-English translation of NCT06873555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Solid Tumors research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new oral medication called in patients whose cancers have come back or stopped responding to standard treatments. The study has two phases: first, researchers will confirm the right dose and watch for side effects in different cancer types; then, if the results look promising, they'll expand testing in a second phase to learn more about how well this medication works.
Many patients with advanced ovarian cancer, lung cancer, and other solid tumors run out of effective treatment options when their cancers stop responding to standard therapies. This medication is being studied to see if it can help patients in this difficult situation.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth once daily, every day, in 4-week treatment cycles. The study has two parts: in Part A, you'll be in one of three groups based on your cancer type, and researchers will monitor your safety, side effects, and how well the medication is working through regular clinic visits and lab tests. Depending on how Part A goes, Part B may expand to enroll more patients for further evaluation. Throughout the trial, you'll have imaging scans, blood tests, and regular check-ins with your doctor to track your progress.
AI-generated summary from trial data · Sep 19, 2026 · Not medical advice
China